NSI N.V. 16.380 € (-1,56 %)
SHELL PLC 38.210 € (+0,79 %)
CAPITAL B 0.507 € (+6,13 %)
ATLAND 33.600 € (+0,30 %)
GENFIT 14.060 € (+3,69 %)
RELX 28.900 € (-2,69 %)
ABIONYX PHARMA 1.864 € (+1,19 %)
TKH GROUP 42.980 € (+1,27 %)
CORBION 19.410 € (-1,87 %)
MAISONS DU MONDE 0.188 € (-2,19 %)
LEGRAND 137.250 € (+1,59 %)
CREDIT AGRICOLE 18.105 € (+0,98 %)
TIKEHAU CAPITAL 17.360 € (-2,03 %)
CARBIOS 6.800 € (+23,41 %)
ARCELORMITTAL SA 57.860 € (-0,65 %)
ABN AMRO BANK N.V. 38.190 € (+2,00 %)
PROSUS 38.495 € (-3,70 %)
DSM FIRMENICH AG 83.980 € (-2,12 %)
WOLTERS KLUWER 60.000 € (-2,31 %)
PLANISWARE 20.000 € (-4,08 %)
ALTEN 55.300 € (-2,12 %)
BNP PARIBAS ACT.A 105.160 € (+1,80 %)
THEON INTERNAT 32.980 € (+2,93 %)
SEMCO TECHNOLOGIES 43.200 € (+4,10 %)
KAUFMAN ET BROAD 26.150 € (+1,16 %)
BILENDI 15.320 € (+2,68 %)
WORLDLINE 10.160 € (+2,77 %)
X-FAB 7.450 € (+7,74 %)
AEGON 8.020 € (+0,35 %)
ATOS GROUP 28.620 € (-5,23 %)
PEUGEOT INVEST 56.100 € (+1,08 %)
ASML HOLDING 1 593.400 € (+4,77 %)
AUBAY 53.000 € (-2,03 %)
IMCD 87.960 € (-0,43 %)
UNILEVER 53.440 € (-2,21 %)
SIRIUS MEDIA 0.640 € (-3,00 %)
BUREAU VERITAS 27.060 € (-1,53 %)
VICAT 60.800 € (-0,16 %)
AKZO NOBEL 57.160 € (-0,45 %)
INPOST 15.500 € (+0,26 %)
L'OREAL 378.750 € (-0,43 %)
BENETEAU 6.100 € (-0,97 %)
UMG 18.500 € (+0,27 %)
ORANGE 16.185 € (-1,52 %)
WENDEL 80.050 € (-0,87 %)
STMICROELECTRONICS 57.250 € (+4,26 %)
ARCADIS 34.380 € (-0,87 %)
BAM GROEP KON 11.670 € (+2,01 %)
JCDECAUX 21.860 € (-1,44 %)
LAKEFRONT BIOTHER. 25.640 € (-0,23 %)
AIR LIQUIDE 176.520 € (-0,66 %)
AXA 44.790 € (+0,07 %)
BASIC-FIT 30.680 € (-0,78 %)
CARREFOUR 16.545 € (-1,16 %)
HEINEKEN 76.920 € (-0,44 %)
SLIGRO FOOD GROUP 11.520 € (-3,52 %)
HEXAOM 27.200 € (-2,86 %)
KPN KON 4.247 € (-1,14 %)
GETLINK SE 18.790 € (+0,05 %)
MAUNA KEA TECH 0.170 € (+6,25 %) |
16/07/2026 09:00
GIMM Festival brings leading microbiology experts to Lisbon to discuss emerging viruses, antimicrobial resistance and biological engineeringEQS-News: Fundação GIMM - Gulbenkian Institute for Molecular Medicine / Key word(s): Miscellaneous Charles M. Rice (2020 Nobel Prize in Medicine), Bonnie Bassler, Yasmine Belkaid and Isabel Gordo are among the confirmed speakers. LISBON, Portugal, July 16, 2026 /PRNewswire/ -- Bacteria are continuously evolving and becoming increasingly resistant to life-saving medicines. Understanding how microorganisms adapt, communicate and influence human health is now a global scientific priority. This will be one of the central themes of the second edition of the GIMM Festival, taking place in Lisbon from 17 to 19 September.
Under the theme 'Microbes – The Questions of the Future', the festival will bring together internationally renowned researchers to explore the role of microorganisms in human health, biological evolution and ecosystem sustainability. The event aims to foster dialogue between science, society and biomedical innovation, at a time when challenges such as pandemics, antimicrobial resistance and environmental change are raising urgent new questions for research and policy. The programme features some of the most influential names in contemporary microbiology:
Over three days, researchers and the public will engage in discussions on major scientific challenges of the 21st century, including host–microbe interactions and disease, antimicrobial resistance and bacterial evolution, emerging viruses and preparedness for future pandemics, as well as microorganism engineering and synthetic biology. Antimicrobial resistance is considered by the World Health Organization one of the greatest threats to global health, with the potential to cause millions of deaths in the coming decades if no effective action is taken. At the same time, advances in microbiome research and the growing capacity to engineer microorganisms are transforming fields such as medicine, biotechnology and environmental sustainability, opening new possibilities for prevention, diagnosis and treatment. "The microscopic world has a profound impact on our health, ecosystems and the future of biotechnology. The GIMM Festival aims to bring researchers and society closer together to discuss how these discoveries can shape the future," says Maria Manuel Mota, CEO of the Gulbenkian Institute for Molecular Medicine. With the participation of world-leading scientists, including a Nobel laureate, the GIMM Festival positions Lisbon as an international hub for scientific debate, reinforcing its role as a meeting point for cutting-edge research and innovation in microbiology and global health. The full programme and registration are available at www.gimmfest.pt. About the Gulbenkian Institute for Molecular Medicine (GIMM) About the GIMM Festival Press Contacts
![]() 16.07.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. 2366628 16.07.2026 CET/CEST Source : Webdisclosure.com |
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière

